42 related articles for article (PubMed ID: 3748273)
1. Effects of Natural Products on Neuromuscular Junction.
Akkol EK; Karatoprak GŞ; Carpar E; Hussain Y; Khan H; Aschner M
Curr Neuropharmacol; 2022 Mar; 20(3):594-610. PubMed ID: 34561984
[TBL] [Abstract][Full Text] [Related]
2. PET Imaging Estimates of Regional Acetylcholine Concentration Variation in Living Human Brain.
Smart K; Naganawa M; Baldassarri SR; Nabulsi N; Ropchan J; Najafzadeh S; Gao H; Navarro A; Barth V; Esterlis I; Cosgrove KP; Huang Y; Carson RE; Hillmer AT
Cereb Cortex; 2021 May; 31(6):2787-2798. PubMed ID: 33442731
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological management of anticholinergic delirium - theory, evidence and practice.
Dawson AH; Buckley NA
Br J Clin Pharmacol; 2016 Mar; 81(3):516-24. PubMed ID: 26589572
[TBL] [Abstract][Full Text] [Related]
4. Effect of acute soman exposure on GABA(A) receptors in rat hippocampal slices and cultured hippocampal neurons.
Wang Y; Liu L; Weiss T; Stewart C; Mikler J
Neurotox Res; 2011 Nov; 20(4):343-50. PubMed ID: 21643853
[TBL] [Abstract][Full Text] [Related]
5. Protective effects of N-methyl-D-aspartate receptor antagonism on VX-induced neuronal cell death in cultured rat cortical neurons.
Wang Y; Weiss MT; Yin J; Tenn CC; Nelson PD; Mikler JR
Neurotox Res; 2008; 13(3-4):163-72. PubMed ID: 18522896
[TBL] [Abstract][Full Text] [Related]
6. Postoperative pain management and proinflammatory cytokines: animal and human studies.
Shavit Y; Fridel K; Beilin B
J Neuroimmune Pharmacol; 2006 Dec; 1(4):443-51. PubMed ID: 18040817
[TBL] [Abstract][Full Text] [Related]
7. The cholinergic pharmacology of tetrahydroaminoacridine in vivo and in vitro.
Hunter AJ; Murray TK; Jones JA; Cross AJ; Green AR
Br J Pharmacol; 1989 Sep; 98(1):79-86. PubMed ID: 2804555
[TBL] [Abstract][Full Text] [Related]
8. Physostigmine--an overview as pretreatment drug for organophosphate intoxication.
Somani SM; Dube SN
Int J Clin Pharmacol Ther Toxicol; 1989 Aug; 27(8):367-87. PubMed ID: 2676871
[TBL] [Abstract][Full Text] [Related]
9. Relation of brain regional physostigmine concentration to cholinesterase activity and acetylcholine and choline levels in rat.
Hallak M; Giacobini E
Neurochem Res; 1986 Jul; 11(7):1037-48. PubMed ID: 3748273
[TBL] [Abstract][Full Text] [Related]
10. The effect of heptyl-physostigmine, a new cholinesterase inhibitor, on the central cholinergic system of the rat.
De Sarno P; Pomponi M; Giacobini E; Tang XC; Williams E
Neurochem Res; 1989 Oct; 14(10):971-7. PubMed ID: 2608162
[TBL] [Abstract][Full Text] [Related]
11. A comparison of the effects of two inhibitors on brain cholinesterase.
Hallak M; Giacobini E
Neuropharmacology; 1987 Jun; 26(6):521-30. PubMed ID: 3601008
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and pharmacodynamics of physostigmine in the rat after oral administration.
Somani SM
Biopharm Drug Dispos; 1989; 10(2):187-203. PubMed ID: 2706318
[TBL] [Abstract][Full Text] [Related]
13. In vivo dose response relationship between physostigmine and cholinesterase activity in RBC and tissues of rats.
Somani SM; Dube SN
Life Sci; 1989; 44(25):1907-15. PubMed ID: 2739507
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
